246 related articles for article (PubMed ID: 19175801)
1. Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier.
Pawar RD; Castrezana-Lopez L; Allam R; Kulkarni OP; Segerer S; Radomska E; Meyer TN; Schwesinger CM; Akis N; Gröne HJ; Anders HJ
Immunology; 2009 Sep; 128(1 Suppl):e206-21. PubMed ID: 19175801
[TBL] [Abstract][Full Text] [Related]
2. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
[TBL] [Abstract][Full Text] [Related]
4. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
Kikawada E; Lenda DM; Kelley VR
J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
[TBL] [Abstract][Full Text] [Related]
5. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
[TBL] [Abstract][Full Text] [Related]
6. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice.
Patole PS; Pawar RD; Lech M; Zecher D; Schmidt H; Segerer S; Ellwart A; Henger A; Kretzler M; Anders HJ
Nephrol Dial Transplant; 2006 Nov; 21(11):3062-73. PubMed ID: 16954173
[TBL] [Abstract][Full Text] [Related]
7. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
8. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
Hu L; Hu J; Chen L; Zhang Y; Wang Q; Yang X
Front Immunol; 2021; 12():584414. PubMed ID: 33717066
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis.
Fan X; Wüthrich RP
Inflammation; 1997 Feb; 21(1):105-12. PubMed ID: 9179626
[TBL] [Abstract][Full Text] [Related]
11. Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice.
Menke J; Bork T; Kutska B; Byrne KT; Blanfeld M; Relle M; Kelley VR; Schwarting A
Kidney Int; 2011 Feb; 79(4):452-63. PubMed ID: 20980973
[TBL] [Abstract][Full Text] [Related]
12. The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.
Moreth K; Brodbeck R; Babelova A; Gretz N; Spieker T; Zeng-Brouwers J; Pfeilschifter J; Young MF; Schaefer RM; Schaefer L
J Clin Invest; 2010 Dec; 120(12):4251-72. PubMed ID: 21084753
[TBL] [Abstract][Full Text] [Related]
13. Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis.
Benz PS; Fan X; Wüthrich RP
Kidney Int; 1996 Jul; 50(1):156-63. PubMed ID: 8807584
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.
Pawar RD; Ramanjaneyulu A; Kulkarni OP; Lech M; Segerer S; Anders HJ
J Am Soc Nephrol; 2007 Jun; 18(6):1721-31. PubMed ID: 17460144
[TBL] [Abstract][Full Text] [Related]
15. Preservations of nephrin and synaptopodin by recombinant hepatocyte growth factor in podocytes for the attenuations of foot process injury and albuminuria in nephritic mice.
Kato T; Mizuno S; Nakamura T
Nephrology (Carlton); 2011 Mar; 16(3):310-8. PubMed ID: 21342325
[TBL] [Abstract][Full Text] [Related]
16. Blockade of Notch1 Signaling Alleviated Podocyte Injury in Lupus Nephritis Via Inhibition of NLRP3 Inflammasome Activation.
Wu D; Jiang T; Zhang S; Huang M; Zhu Y; Chen L; Zheng Y; Zhang D; Yu H; Yao G; Sun L
Inflammation; 2024 Apr; 47(2):649-663. PubMed ID: 38085465
[TBL] [Abstract][Full Text] [Related]
17. Nestin protects podocyte from injury in lupus nephritis by mitophagy and oxidative stress.
Tian Y; Guo H; Miao X; Xu J; Yang R; Zhao L; Liu J; Yang L; Gao F; Zhang W; Liu Q; Sun S; Tian Y; Li H; Huang J; Gu C; Liu S; Feng X
Cell Death Dis; 2020 May; 11(5):319. PubMed ID: 32371936
[TBL] [Abstract][Full Text] [Related]
18. Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritis.
Qi YY; Zhou XJ; Cheng FJ; Hou P; Ren YL; Wang SX; Zhao MH; Yang L; Martinez J; Zhang H
Ann Rheum Dis; 2018 Dec; 77(12):1799-1809. PubMed ID: 30209031
[TBL] [Abstract][Full Text] [Related]
19. Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function.
Ichinose K; Ushigusa T; Nishino A; Nakashima Y; Suzuki T; Horai Y; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Arima K; Nakamura H; Obata Y; Yamamoto K; Origuchi T; Nishino T; Kawakami A; Tsokos GC
Arthritis Rheumatol; 2016 Apr; 68(4):944-52. PubMed ID: 26636664
[TBL] [Abstract][Full Text] [Related]
20. Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis.
Xu C; Miao Y; Pi Q; Zhu S; Li F
Clin Immunol; 2018 Dec; 197():179-185. PubMed ID: 30296590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
